Solid Biosciences (SLDB) EBT Margin (2022 - 2024)
Historic EBT Margin for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 50728.0%.
- Solid Biosciences' EBT Margin changed N/A to 50728.0% in Q4 2024 from the same period last year, while for Dec 2024 it was 35470.29%, marking a year-over-year decrease of 447859000.0%. This contributed to the annual value of 35470.29% for FY2024, which is N/A changed from last year.
- Latest data reveals that Solid Biosciences reported EBT Margin of 50728.0% as of Q4 2024.
- Over the past 5 years, Solid Biosciences' EBT Margin peaked at 50728.0% during Q4 2024, and registered a low of 406.69% during Q2 2022.
- In the last 3 years, Solid Biosciences' EBT Margin had a median value of 27173.88% in 2024 and averaged 28319.87%.
- Examining YoY changes over the last 5 years, Solid Biosciences' EBT Margin showed a top increase of 5009700bps in 2024 and a maximum decrease of 5009700bps in 2024.
- Over the past 3 years, Solid Biosciences' EBT Margin (Quarter) stood at 406.69% in 2022, then soared by 6268bps to 25084.3% in 2023, then soared by 102bps to 50728.0% in 2024.
- Its EBT Margin stands at 50728.0% for Q4 2024, versus 40165.85% for Q3 2024 and 28762.5% for Q2 2024.